Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$8 Mln
Revenue (TTM)
$20 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.1 %
ROCE
-- %
P/E Ratio
0
P/B Ratio
11.1
Industry P/E
28.33
EV/EBITDA
4
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$-0.1
Face value
--
Shares outstanding
8,908,410
CFO
$-71.91 Mln
EBITDA
$3.24 Mln
Net Profit
$-159.88 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
cbdMD (YCBD)
| -72.1 | -11.8 | -60.5 | -83.5 | -83.2 | -72.6 | -- |
|
BSE Sensex*
| 4.1 | -1.1 | 8.1 | 5.3 | 16.6 | 18.9 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
cbdMD (YCBD)
| -63.6 | -89.8 | -79.0 | -63.4 | 30.5 | -26.9 | -28.8 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
cbdMD (YCBD)
|
0.8 | 7.6 | 19.6 | -1.2 | 4.6 | -0.3 | 0 | 11.1 |
| 18.1 | 4,870.2 | 459.4 | 206.8 | 25.6 | 68.3 | 24.3 | 13.3 | |
| 29.3 | 3,591.5 | 8.9 | -369.2 | -4,861.1 | -26.1 | -- | 2.7 | |
| 102.9 | 5,125.5 | 432.2 | -278.3 | -64.1 | -380.9 | -- | 94.0 | |
| 55.2 | 10,785.5 | 2,937.8 | 523.9 | 23.2 | 9.3 | 20.8 | 1.9 | |
| 40.0 | 7,811.7 | 127.4 | -668.0 | -432.9 | -- | -- | 123.7 | |
| 71.2 | 7,619.3 | 685.5 | 132.9 | 15.6 | 20.1 | 61.9 | 11.0 | |
| 13.3 | 6,948.1 | 4,427.0 | 373.0 | -0.7 | 5.8 | 18.1 | 1.1 | |
| 83.6 | 4,135.0 | 1,137.8 | 214.6 | 29.2 | 12.3 | 19.5 | 2.3 | |
| 8.8 | 10,281.4 | 14,317.0 | -3,790.1 | -23.7 | -21.4 | -- | 0.7 |
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB... tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina. Address: 2101 Westinghouse Blvd, Charlotte, NC, United States, 28273 Read more
Interim CEO, CFO & Principal Executive Officer
Mr. T. Ronan Kennedy
Interim CEO, CFO & Principal Executive Officer
Mr. T. Ronan Kennedy
Headquarters
Charlotte, NC
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of cbdMD Inc (YCBD) stood at $ 21 Mln as on 31-Mar-25
The share price of cbdMD Inc (YCBD) is $0.84 (NYSE) as of 18-Jun-2025 16:10 EDT. cbdMD Inc (YCBD) has given a return of -83.19% in the last 3 years.
cbdMD Inc (YCBD) has a market capitalisation of $ 8 Mln as on 18-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of cbdMD Inc (YCBD) is 11.08 times as on 18-Jun-2025, a 129% premium to its peers’ median range of 4.83 times.
The P/E ratio of cbdMD Inc (YCBD) is 0.01 times as on 18-Jun-2025, a 100% discount to its peers’ median range of 28.33 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the cbdMD Inc (YCBD) and enter the required number of quantities and click on buy to purchase the shares of cbdMD Inc (YCBD).
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina. Address: 2101 Westinghouse Blvd, Charlotte, NC, United States, 28273
The CEO & director of Mr. T. Ronan Kennedy. is cbdMD Inc (YCBD), and CFO & Sr. VP is Mr. T. Ronan Kennedy.
There is no promoter pledging in cbdMD Inc (YCBD).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,096
|
|
|
1,054
|
|
|
755
|
|
|
741
|
|
|
709
|
|
|
532
|
|
|
522
|
|
|
421
|
|
|
386
|
| cbdMD Inc. (YCBD) | Ratios |
|---|---|
|
Return on equity(%)
|
-0.35
|
|
Operating margin(%)
|
4.59
|
|
Net Margin(%)
|
-5.92
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of cbdMD Inc (YCBD) was $0 Mln.
$0.02
(
